BioCentury | Apr 25, 2011
Finance

Karolinska's Cash Cushion

...Dec. 31. The fund has raised SEK1.4 billion ($224.7 million) since its inception in 2003. SEB Enskilda...
BioCentury | Apr 25, 2011
Financial News

Karolinska Development completes IPO

...SEK608 million (US$97.6 million) Shares: 15.2 million Price: SEK40 Shares after offering: 48.5 million Underwriters: SEB Enskilda...
BioCentury | Apr 20, 2011
Financial News

Karolinska prices IPO

...that have reached "later and more costly clinical development phases" (see BioCentury, April 4) . SEB Enskilda...
BioCentury | Apr 4, 2011
Financial News

Karolinska Development proposes IPO

...Type: IPO To be raised: SEK421.8-SEK478.8 million ($66-$74.9 million) Shares: 11.4 million Price: SEK37-SEK42 Underwriters: SEB Enskilda...
BioCentury | Apr 4, 2011
Finance

Next Phase for Karolinksa

...the public and institutional investors in Sweden, and to institutional investors outside of the country. SEB Enskilda...
BioCentury | Mar 29, 2011
Financial News

Karolinska planning IPO

...clinical development phases." At Dec. 31, 2010, Karolinska had SEK210 million ($31.2 million) in cash. SEB Enskilda...
BioCentury | Feb 21, 2011
Financial News

Biotec Pharmacon completes private placement

...million ($1.3 million) Shares: 1.2 million Price: NOK6.30 Shares after offering: 28.3 million Placement agent: SEB Enskilda...
BioCentury | Dec 6, 2010
Financial News

Zealand Pharma completes IPO

...Price: DKK86 Shares after offering: 22 million Underwriters: Danske Bank, Jefferies, Bryan, Garnier & Co., SEB Enskilda...
BioCentury | Dec 6, 2010
Finance

Holiday discounts

...Group (Euronext:SAN; NYSE:SNY). Danske Markets and Jefferies were joint global coordinators, while Bryan, Garnier and SEB Enskilda...
BioCentury | Nov 24, 2010
Top Story

Zealand leads trio of IPOs

...million shares outstanding. Danske Markets and Jefferies were joint global coordinators, while Bryan, Garnier and SEB Enskilda...
Items per page:
1 - 10 of 25
BioCentury | Apr 25, 2011
Finance

Karolinska's Cash Cushion

...Dec. 31. The fund has raised SEK1.4 billion ($224.7 million) since its inception in 2003. SEB Enskilda...
BioCentury | Apr 25, 2011
Financial News

Karolinska Development completes IPO

...SEK608 million (US$97.6 million) Shares: 15.2 million Price: SEK40 Shares after offering: 48.5 million Underwriters: SEB Enskilda...
BioCentury | Apr 20, 2011
Financial News

Karolinska prices IPO

...that have reached "later and more costly clinical development phases" (see BioCentury, April 4) . SEB Enskilda...
BioCentury | Apr 4, 2011
Financial News

Karolinska Development proposes IPO

...Type: IPO To be raised: SEK421.8-SEK478.8 million ($66-$74.9 million) Shares: 11.4 million Price: SEK37-SEK42 Underwriters: SEB Enskilda...
BioCentury | Apr 4, 2011
Finance

Next Phase for Karolinksa

...the public and institutional investors in Sweden, and to institutional investors outside of the country. SEB Enskilda...
BioCentury | Mar 29, 2011
Financial News

Karolinska planning IPO

...clinical development phases." At Dec. 31, 2010, Karolinska had SEK210 million ($31.2 million) in cash. SEB Enskilda...
BioCentury | Feb 21, 2011
Financial News

Biotec Pharmacon completes private placement

...million ($1.3 million) Shares: 1.2 million Price: NOK6.30 Shares after offering: 28.3 million Placement agent: SEB Enskilda...
BioCentury | Dec 6, 2010
Financial News

Zealand Pharma completes IPO

...Price: DKK86 Shares after offering: 22 million Underwriters: Danske Bank, Jefferies, Bryan, Garnier & Co., SEB Enskilda...
BioCentury | Dec 6, 2010
Finance

Holiday discounts

...Group (Euronext:SAN; NYSE:SNY). Danske Markets and Jefferies were joint global coordinators, while Bryan, Garnier and SEB Enskilda...
BioCentury | Nov 24, 2010
Top Story

Zealand leads trio of IPOs

...million shares outstanding. Danske Markets and Jefferies were joint global coordinators, while Bryan, Garnier and SEB Enskilda...
Items per page:
1 - 10 of 25